Regulated Expiratory Breathing Method During Childbirth
Results of Regulated Expiratory Breathing Method During Childbirth Process
1 other identifier
interventional
120
1 country
1
Brief Summary
The factors affecting the rate of primary caesarean section births are complex, and identifying interventions to reduce this rate is challenging. Effective interventions targeting at women are mainly represented by Childbirth training workshops, psychoeducation and psychosocial couple-based programs. Considering non medical interventions targeting mothers, the pattern of breathing during labor that can help for vaginal delivery is a controversial topic. There are no data to support a policy of directed maternal breathing or pushing during vaginal delivery. The abdomino-perineal concept was originally a postpartum rehabilitation technique. Currently, applications are increasing. During labor, expiration channeled by a flow regulator device offers support to women enduring the pain of uterine contractions. During the second stage, the expiratory regulated pushing allows a long, efficient and very intuitive push. The use of this regulated expiratory breathing method was introduced in the study unit in January 2018. Despite a positive experience both reported by women and midwives, investigators have so far only subjective feedback without objective measurable clinical impact. As a result, investigators are conducting this scientific study whose main objective is: \- To Evaluate the impact of a regulated expiratory breathing method on childbirth process .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2019
CompletedFirst Posted
Study publicly available on registry
January 7, 2020
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2021
CompletedMarch 16, 2021
March 1, 2021
1.1 years
December 19, 2019
March 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cesarean delivery rate
percentage of cesarean delivery in each group
through study completion, an average of 1 year
Secondary Outcomes (8)
Duration of first stage of labor
up to 10 hours . In deed , For each recruited patient this outcome will be measured in minutes between onset of labor and achievement of complete cervical dilation
Duration of the second stage of labor
up to one hour . In deed, investigators will measure for each included patient the time ( minutes ) elapsed from complete cervical dilation and newborn delivery
duration of placental delivery
up to 20 minutes .Investigators will measure for each included patient the time in minutes elapsed between newborn delivery and placental expulsion.
Rate of Spontaneous vaginal birth
through study completion, an average of 1 year
Rate of Instrumental vaginal birth
through study completion, an average of 1 year
- +3 more secondary outcomes
Study Arms (2)
WINNER- FLOW-URO-MG GROUP
EXPERIMENTALAfter admission to the delivery room, all women assigned to WF + group will have an interview with one of the midwifes responsible for the study. The latter will explain the use of the WINNER FLOW®-URO MG® device which is the expiration mouthpiece used during breathing exercises to ensure a constant ventilatory flowrate. Then, WF+ patients will use the expiratory mouthpiece device during all their childbirth process.
NO WINNER-FLOW-URO-MG GROUP
NO INTERVENTIONWomen enrolled in WF- group will be managed classically during their child birth process regardless to the study participation.
Interventions
women enrolled in WINNER-FLOW-URO-MG group will freely use the expiratory mouthpiece device during all their childbirth process.
Eligibility Criteria
You may qualify if:
- Primiparae
- Singleton pregnancy
- Gestational age ≥ 37 SA
- Fetus in cephalic presentation
- Fetus with a normal weight for a the gestational age
- Spontaneous onset of labor
- Early stage of labor (with cervical dilatation under 3 cm)
- No previous Childbirth training workshops
You may not qualify if:
- Parity of at least 2
- Multiple pregnancy
- Intra uterine fetal demise
- Previous uterine scar
- Fetus in Breach presentation
- Non Vertex cephalic presentation
- Narrowed pelvic bone diameters
- A contraindication to vaginal delivery (placenta previa , fibroma previa, …)
- Previous participation to childbirth training workshops
- Women in an advanced stage of labor with a cervical dilation upon admission over 3 cm
- Women requiring epidural anesthesia
- Refusal of participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mongi Slim University Hospital
Tunis, Sidi Daoued La Marsa, 2045, Tunisia
Related Publications (1)
Dimassi K, Halouani A, Ben Zina F, Khemessi N, Triki A. Regulated Expiratory Methods During Childbirth Process: A Randomized Controlled Trial. J Obstet Gynaecol Can. 2024 Mar;46(3):102265. doi: 10.1016/j.jogc.2023.102265. Epub 2023 Nov 7.
PMID: 37940044DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
December 19, 2019
First Posted
January 7, 2020
Study Start
February 1, 2020
Primary Completion
March 15, 2021
Study Completion
March 15, 2021
Last Updated
March 16, 2021
Record last verified: 2021-03